Fretschner M, Endlich K, Gulbins E, Lang R E, Schlottmann K, Steinhausen M
Department of Physiology, University of Heidelberg, FRG.
Ren Physiol Biochem. 1991 May-Jun;14(3):112-27. doi: 10.1159/000173394.
We have examined the effects of endothelin (ET) on the renal microcirculation by in vivo microscopy using the model of the split hydronephrotic rat kidney. ET, a potent vasoconstrictor peptide synthesized by vascular endothelial cells, showed marked and long-lasting effects on glomerular blood flow and vessel diameters in various segments of the renal vascular bed. Intravenously applied ET (100 ng/min/kg) increased systemic blood pressure from 123 +/- 7 to 156 +/- 4 mm Hg, decreased glomerular blood flow by 70%, and preferentially constricted larger preglomerular vessels, e.g. the arcuate artery. The competitive leukotriene antagonist FPL55712 significantly attenuated the vasoconstrictor response of the larger vessels. Local ET administration decreased glomerular blood flow in a dose-dependent manner (50% reduction at a concentration of 2.6 +/- 0.7 x 10(-9) M) and constricted smaller vessel segments, e.g. the afferent and efferent arterioles near the glomerulus. The constriction induced by ET was not significantly affected by the Ca2+ channel blocker nitrendipine (2.8 x 10(-6) to 1.1 x 10(-5) M). We conclude that intravenous ET effects are probably mediated by leukotrienes, inducing constriction of larger renal vessels. Locally administered ET acts directly on the renal vasculature, especially on smaller vessels.
我们使用肾积水大鼠肾脏分离模型,通过体内显微镜检查了内皮素(ET)对肾微循环的影响。ET是一种由血管内皮细胞合成的强效血管收缩肽,对肾血管床各节段的肾小球血流和血管直径具有显著且持久的影响。静脉注射ET(100 ng/min/kg)可使全身血压从123±7 mmHg升高至156±4 mmHg,使肾小球血流减少70%,并优先收缩较大的肾小球前血管,如弓形动脉。竞争性白三烯拮抗剂FPL55712可显著减弱较大血管对ET的血管收缩反应。局部给予ET可使肾小球血流呈剂量依赖性减少(在浓度为2.6±0.7×10⁻⁹ M时减少50%),并使较小的血管节段收缩,如肾小球附近的入球小动脉和出球小动脉。ET诱导的血管收缩不受Ca²⁺通道阻滞剂尼群地平(2.8×10⁻⁶至1.1×10⁻⁵ M)的显著影响。我们得出结论,静脉注射ET的作用可能由白三烯介导,导致较大肾血管收缩。局部给予ET直接作用于肾血管系统,尤其是较小的血管。